The COVID-19 pandemic has led to a dramatic loss of human life worldwide and presents an unprecedented challenge to public health, food systems and the world of work. Amidst all this, the distribution and administration of the Covid vaccines has given people hope, but there are several unanswered questions and some skepticism about the efficacy of the vaccines.
Second in a series of webinars, a discussion organized virtually Feb. 26 by the Global Organization of Persons of Indian Originâs Manhattan chapter in collaboration with the Indian Consulate in New York provided answers to some of these questions.
Attended by people from around the globe, the webinar, led by Hana Akselrod, M.D., MPH, attempted to answer questions on the pandemic, how it spreads and ways to prevent and mitigate the spread.
Bicara Therapeutics Launches with Deep Pipeline of First-in-Class Dual Action Biologics for Cancer Immunotherapy
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
Commemorating the Contributions of Cancer Research Greats
March 12, 2021, by Norman E. Sharpless, M.D.
Dr. Emil Freireich, who died in February 2021, working with a blood cell separator at MD Anderson Cancer Center.
Credit: National Cancer Institute
There are those moments, those events that make it the ideal time to stop and reflect on the past.
Such is the case with the passing of Dr. Emil Freireich, who died last month at the age of 93 in Houston, his long-time home. Having begun his career in the 1950s at NCI, Dr. Freireich went on to become one of the most accomplished physician–scientists to ever step into a lab or comfort a worried patient.
E-Mail
IMAGE: Three receptor tyrosine kinases (RTKs) EGFR (orange), HER2 (pink), and MET (green) are imaged before and after the use of a MET-selective tyrosine kinase inhibitor (Trametinib), and trametinib, a mitogen activated protein. view more
Credit: Image created by Patricia Pereira, PhD, Research Associate at Memorial Sloan Kettering Cancer Center
Reston, VA Immuno-positron emission tomography (PET) imaging can provide early insight into a tumor s response to targeted therapy, allowing physicians to select the most effective treatment for patients who have cancer. The new research was published in the March issue of The
Journal of Nuclear Medicine.
The research showed that immuno-PET successfully visualizes changes in different cancer receptors (receptor tyrosine kinases, or RTKs) within tumors during targeted therapies. This gives physicians a tool that can be used to evaluate the effectiveness of a treatment soon after its administration.
Share this article
Share this article
NEW YORK, March 10, 2021 /PRNewswire/ John E. Kehoe, MD, is being recognized by Continental Who s Who as a Top Breast Cancer Surgeon 2021 for his remarkable achievements in the field of Medicine and for his exceptional work ethic as a Breast Cancer Surgeon and Surgical Oncologist with his private practice.
(PRNewsfoto/Continental Who s Who)
Situated at 9711 3rd. Avenue, Dr. John Kehoe Breast Center is an innovative breast center facility in Brooklyn that has provided comprehensive breast medical care from screening and diagnosis to breast cancer treatment. For years, the center has been built on the foundation that every woman should have a specialized breast doctor as she has a gynecologist. Dr. Kehoe and his dedicated staff make themselves available to any woman who is concerned about their findings or what someone else found on the breast exam. Treatment plans are created according to each patient s routine breast care, or diagnosis fro
vimarsana © 2020. All Rights Reserved.